Search
Now showing items 1-10 of 21
Treatment of hepatitis C virus infection in patients of northern India
(2004)
BACKGROUND AND AIM: The purpose of the present study was to evaluate the therapeutic response of north Indian patients with chronic hepatitis C (CH-C) to two different treatment regimens of interferon and ribavirin. METHODS: ...
Hepatitis G virus in India.
(1996)
Genotype determination of hepatitis C virus from northern India: identification of a new subtype.J Med Virol.
(1996)
Hepatitis C virus (HCV) shows substantial nucleotide sequence diversity distributed throughout the viral genome, with many variants showing only 68-79% overall sequence homology. This has led to problems in diagnosis of ...
Etiological role of hepatitis E virus in sporadic fulminant hepatitis
(1994)
Non-A, non-B hepatitis viruses have been implicated as the etiological agent(s) in up to 60% of patients with fulminant hepatitis. These agents are reported to induce a higher mortality than other causes of fulminant ...
Diagnosis of hepatitis C virus-associated chronic liver disease in India: comparison of HCV antibody assay with a polymerase chain reaction for the 5' noncoding region.
(1994)
The relative value of an anti-hepatitis C virus (HCV) serological assay and reverse transcriptase-nested polymerase chain reaction assays (RT-PCR) were investigated for the constant 5' putative noncoding region of HCV for ...
Chronic hepatitis in a large Indian hospital.
(1993)
BACKGROUND. In developed countries as well as in Southeast Asia, the hepatitis B and C viruses are the main causes of chronic hepatitis. In India, however, there have been no major investigations on the aetiology of chronic ...
Immune response to hepatitis B virus surface antigen peptides during HBV infection.
(1992)
Antibody responses of patients with acute (n = 73), fulminant (n = 30) and chronic (n = 51) hepatitis B virus (HBV) infection as well as recovered individuals (n = 7) were studied against three synthetic peptides, Pre-S1 ...
Vitamin E-based therapy is effective in ameliorating transaminasemia in nonalcoholic fatty liver disease
(2005)
BACKGROUND: Comparative trials of ursodeoxycholic acid (UDCA), vitamin E and weight management programs among patients with nonalcoholic fatty liver disease (NAFLD) are lacking. AIM: To find an effective single agent or ...
Vaccination for hepatitis A virus is not required for patients with chronic liver disease in India
(2002)
BACKGROUND: Hepatitis A virus (HAV) vaccination is recommended worldwide for patients with chronic liver disease to prevent decompensation due to superinfection with HAV. India being endemic for HAV, the prevalence of ...
Occult hepatitis B virus infection in chronic liver disease: full-length genome and analysis of mutant surface promoter
(2004)
BACKGROUND AND AIMS: Genome sequence of hepatitis B virus (HBV) from occult chronic infection is scarce. Fifty-six (9.4%) of 591 patients seronegative for hepatitis B surface antigen (HBsAg) with chronic liver disease were ...